Antibody levels against polioviruses in children following pulse polio immunization program

Indian Pediatrics

Volumn 41, Issue 10, 2004, Pages 1040-1044

  Hasan, Azra S ^b   Malik, Abida ^b   Shukla, Indu ^b   Malik, M Ashraf ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Oral polio vaccine; Pulse polio immunization; Seropositivity

Indexed keywords

ORAL POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ANAMNESIS; ANTIBODY TITER; ARTICLE; GEOMETRY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INDIA; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PULSE POLIO IMMUNIZATION; SERODIAGNOSIS; SEROPREVALENCE; VERO CELL;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMANS; IMMUNIZATION PROGRAMS; INDIA; INFANT; POLIOMYELITIS; POLIOVIRUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 7044255047     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Poliomyelitis surveillance report: SEAR Polio Bulletin, WHO regional office for South-east Asia Vol7, No.36. Available from URL: http://w3.whosea. org/vab/. Accessed Sep 8, 2003.
2. Krugman RD, Hardy GE Jr, Sellers C, Parkman PD, Witte JJ, Meyer BC, et al. Antibody persistence after primary immunization with trivalent oral poliovirus vaccine. Pediatrics 1977; 60: 80-82.
3. Shell Y, Zhao Y, Lin D. Surveillance of levels of neutralizing antibodies against poliovirus among children 0-3 year in rural areas of Anhin province [Abstract]. Zhongua Yu Fang Yi Xue Zazai 1995; 29: 335-338.
4. Su W. A seroepidemiological survey of neutralization antibodies to polioviruses in Lingu and Yu cheng counties of Shangdong Province, China [Abstract]. Zhongua Lin Xing Bing Xue Za Zhi 1991; 12: 146-149.
5. Jaiswal S, Java AM, Thawrani YP, Belapurkar KM. IgG antibody response to OPV immunization. Indian J Med Microbiology 2000; 18: 79-82.
6. Reichler MR, Kharabshah S, Rhodes P, Otoum H, Bloch S, Majid MA et al. Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan. J Infect Dis 1997; 175: S198-S204.
7. Richardson G, Linkins RW, Eames MA, Wood DJ, Minor PD, Patriarca PA. Immunogenicity of oral polio vaccine administered in mass campaigns versus routine Immunization programs. Bull WHO 1995; 73: 769-777.
8. Nightangle O. Recommendations for a national policy on poliomyelitis vaccination. N Engl J Med 1977; 297: 249.
9. Wu CM, Zheng HY, Ren YL. Immune interference of enteroviruses to immune response of OPV in subtropical areas [Abstract]. Zhongua Lin Xing Bing Xue Za Zhi 1996; 17: 233-235.
10. Fine EMP, Carneiro AM. Transmissibility and persistence of oral polio vaccine viruses: Implications for the global poliomyelitis eradication initiative. Am J Epidemiol 1999; 150: 1011-1012.
11. Patriarca PA, Wright PF, John TJ. Factors affecting immunogenicity of oral polio vaccine in developing countries: a review. Rev Inf Dis 1991; 13: 926-939.
12. John TJ, Thacker N, Deshpande JM. Setback in polio eradication in India in 2002: Reasons and remedies. Indian Pediatr 2003; 40: 195-203.